Golalizadeh, Dina
Toopchizadeh, Vahideh
Fasaie, Negar
Dolatkhah, Neda http://orcid.org/0000-0003-1358-1003
Funding for this research was provided by:
Tabriz University of Medical Sciences
Article History
Received: 28 September 2019
Accepted: 11 November 2019
First Online: 20 November 2019
Ethics approval and consent to participate
: At the beginning of the study, the objectives of the design and method were explained in detail, and written informed consent was obtained from participants or a parent or guardian on behalf of any participants under the age of 16. Any adolescent whose parent or guardian did not give consent wasn’t enrolled in the study. The subjects were able to exit the study any time they wanted with no reason. No additional costs, no complications or intervention were imposed on patients, and they were not deprived of their routine therapies. The protocol has been discussed and approved by the Ethics Committee of the Tabriz University of Medical Sciences (IR.TBZMED.REC.1395.773).
: Not applicable.
: The authors declare that they have no competing interests.